by | Aug 2, 2021 | Lupus Foundation of America
This type I interferon receptor antagonist demonstrated early and sustained benefits for people with moderate to severe systemic lupus erythematosus.The U.S. Food and Drug Administration (FDA) has approved Saphnelo™ (anifrolumab-fnia) as a treatment for adults with...
by Stephanie Holmes | Jul 26, 2021 | Lupus Foundation of America
I was 15 years old when I was diagnosed with lupus, I was so sick; I remember my mom taking me to the doctor in a wheelchair, sitting me in front of the receptionist desk and begging for help. I recall making countless visits to our family doctor where I never got any...
by Stephanie Holmes | Jul 13, 2021 | Lupus Foundation of America
The Lupus Foundation of America has renewed its support for the National Institutes of Health (NIH) Accelerating Medicines Partnership (AMP) which recently announced a new initiative to discover the causes of inflammation and clinical disease. The new AMP Autoimmune...
by Stephanie Holmes | Jul 13, 2021 | Lupus Foundation of America
The Sharing the Journey series is by you and for you. In your own words, we highlight the perspectives and personal experiences of people who struggle with lupus each day. This month, we asked Sharing the Journey participants the following question:When you were first...
by | Jul 13, 2021 | Lupus Foundation of America
The Lupus Foundation of America has renewed its support for the National Institutes of Health (NIH) Accelerating Medicines Partnership (AMP) which recently announced a new initiative to discover the causes of inflammation and clinical disease. The new AMP Autoimmune...
by | Jul 13, 2021 | Lupus Foundation of America
The Sharing the Journey series is by you and for you. In your own words, we highlight the perspectives and personal experiences of people who struggle with lupus each day. This month, we asked Sharing the Journey participants the following question:When you were first...
